There are several equations available for estimating GFR. The calculator is based on the equation described in Levey AS, Bosch JP, Lewis JB, et al; A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999 Mar 16;130(6):461-70.
This calculator uses the abbreviated MDRD equation1 (MDRD = Modification of Diet in Renal Disease Study), which is the one recommended by NICE2 and The Renal Association (UK).3
See the accompanying clinical record Assessing Kidney Function.
On this page
Notes
Use the eGFR value calculated by your local laboratory in preference to the above as it is likely to be more accurate (as it may adjust for variations in creatinine measurements).
| Calculator above uses the abbreviated MDRD equation:1 Estimated GFR (ml/min/1.73m2) = 186 x (Creat / 88.4)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if black) |
- Serum creatinine is correlated with muscle mass and therefore estimation of GFR using prediction equations in people with extremes of muscle mass is subject to inaccuracy. In those with increased muscle mass, GFR will be under estimated and in those with reduced muscle mass GFR will be over estimated.2
- This equation is accurate in patients with chronic kidney disease (CKD), but it significantly underestimates GFR in healthy persons (probably due to the exclusion of healthy persons from the study used to develop this equation).4 Do not over-interpret slightly low values.
- Stages 1 or 2 CKD should not be diagnosed on GFR alone - unless there are urinalysis, structural abnormalities or genetic factors to indicate renal disease.
- These calculations assume that the creatinine levels are relatively stable (over a few days) and not rapidly changing.
- The MDRD equation is not valid for children - use the Counahan-Barrat method.5
Stages of Chronic Kidney Disease6
Stages of Chronic Kidney Disease (CKD) Use the suffix (p) to denote the presence of proteinuria when staging CKD. | |||
| Stage | Glomerular Filtration Rate Values are normalized to an average surface area (size) of 1.73m2 | Description | Management |
| I | 90+ | Normal renal function (but urinalysis, structural abnormalities or genetic factors indicate renal disease) | Observation and control of blood pressure |
| II | 60-89 | Mildly reduced renal function (Stage 2 CKD should not be diagnosed on GFR alone - but urinalysis, structural abnormalities or genetic factors indicate renal disease) | Observation, control of blood pressure and cardiovascular risk factors |
| IIIa | 45-59 | Moderate decrease in renal function, with or without other evidence of kidney damage | Observation, control of blood pressure and cardiovascular risk factors |
| IIIb | 30-44 | Moderate decrease in renal function, with or without other evidence of kidney damage | Observation, control of blood pressure and cardiovascular risk factors |
| IV | 15-29 | Severely reduced renal function | Planning for endstage renal failure |
| V | <15 | Very severe (endstage) renal failure | Transplant or dialysis |
Document references
- Levey AS, Bosch JP, Lewis JB, et al; A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999 Mar 16;130(6):461-70. [abstract]
- Chronic kidney disease, NICE Clinical Guideline (September 2008); Early identification and management of chronic kidney disease in adults in primary and secondary care
- The Renal Association (UK) website
- Rule AD, Larson TS, Bergstralh EJ, et al; Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004 Dec 21;141(12):929-37. [abstract]
- Counahan-Barrat method - see Nephron.com website.
- No authors listed; K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.
Acknowledgements
EMIS is grateful to Dr Huw Thomas for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2010.Document ID: 1087
Document Version: 26
Document Reference: bgp1093
Last Updated: 27 Oct 2009